Granulocyte macrophage colony-stimulating factor is the main cytokine enhancing survival of eosinophils in asthmatic airways

European Respiratory Journal

Volumn 12, Issue 4, 1998, Pages 872-878

  Park, C S ^a   Choi, Y S ^b   Ki, S Y ^b   Moon, S H ^b   Jeong, S W ^b   Uh, S T ^b   Kim, Y H ^b  

^a Soonchunhyang University College of Medicine   (South Korea)

^b NONE

Author keywords

Bronchoalveolar lavage fluid; Eosinophils; Granulocyte macrophage colony stimulating factor; Interleukin 3; Interleukin 5; T lymphocytes

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 3; INTERLEUKIN 5; NEUTRALIZING ANTIBODY;

ADULT; ARTICLE; ASTHMA; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; EOSINOPHILIA; FEMALE; HUMAN; HUMAN CELL; LUNG LAVAGE; MALE; PRIORITY JOURNAL; T LYMPHOCYTE;

ADULT; AGED; ASTHMA; BRONCHIAL PROVOCATION TESTS; BRONCHOALVEOLAR LAVAGE FLUID; CELL SURVIVAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; EOSINOPHILS; FEMALE; FLOW CYTOMETRY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; REFERENCE VALUES; RESPIRATORY FUNCTION TESTS; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTES;

EID: 0031723068     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.98.12040872     Document Type: Article

References (33)

1. Bousquet J, Chanez P, Lacoste JY, et al. Eosinophilic inflammation in asthma. N Engl J Med 1990; 323: 1033-1039.
2. Azzawi M, Bradley B, Jeffery PK, et al. Identification of activated T-lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am Rev Respir Dis 1990; 142: 1407-1413.
3. De Monchy JGR, Kauffman HF, Venge P, et al. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am Rev Respir Dis 1985; 131: 373-376.
4. Metzger WJ, Zavala D, Richerson HB, et al. Local allergen challenge and bronchoalveolar lavage of allergic asthmatic lungs: description of the model and local airway inflammation. Am Rev Respir Dis 1987; 135: 433-440.
5. Flavahan NA, Slifman NR, Gleich GJ, Vanhoutte PM. Human eosinophil major protein causes hyperreactivity of respiratory smooth muscle: role of the epithelium. Am Rev Respir Dis 1988; 138: 685-688.
6. Clutterbuck EJ, Hirst EMA, Sanderson CJ. Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3, IL-6 and GM-CSF. Blood 1989; 73: 1504-1512.
7. Yamaguchi Y, Hayashi Y, Sugama Y, et al. Highly purified murine interleukin-5 (IL-5) stimulates eosinophil function and prolongs in vitro survival: IL-5 as an eosinophil chemotactic factor. J Exp Med 1988; 167: 1737-1742.
8. Tai PC, Sun L, Spry CJF. Effect of IL-5, granulocytes/ macrophage colony-stimulating factor (GM-CSF) and IL-3 on the survival of human blood eosinophils in vitro. Clin Exp Immunol 1991; 85: 312-316.
9. Yamaguchi Y, Suda T, Ohta S, Tominaga K, Miura Y, Kasahara T. Analysis of the survival of mature human eosinophils: interleukin-5 prevents apoptosis in mature human eosinophils. Blood 1991; 78: 2542-2547.
10. Virchow JC Jr, Walker C, Hafner D, et al. T cells and cytokines in bronchoalveolar lavage fluid after segmental allergen provocation in atopic asthma. Am J Respir Crit Care Med 1995; 151: 960-968.
11. Zangrilli JG, Shaver JR, Cirelli RA, et al. sVCAM-1 levels after segmental antigen challenge correlate with eosinophil influx, IL-4 and IL-5 production, and the late phase response. Am J Respir Crit Care Med 1995; 151: 1346-1353.
12. Hamid Q, Azzawi M, Ying S, et al. Expression of mRNA for interleukin-5 in mucosal biopsies from asthma. J Clin Invest 1991; 87: 1541-1546.
13. Sousa AR, Poston RN, Lane SJ, Nakhosteen JA, Lee TK. Detection of GM-CSF in asthmatic bronchial epithelium and decrease by inhaled corticosteroids. Am Rev Respir Dis 1993; 147: 1557-1561.
14. 2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992; 326: 298-304.
15. Walker C, Bode E, Boer L, Hansel TT, Blaser K, Virchow JC. Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am Rev Respir Dis 1992; 146: 109-115.
16. Mattoli S, Mattoso VL, Soloperto M, Allergra L, Fasoli A. Cellular and biochemical characteristics of bronchoalveolar lavage fluid in symptomatic nonallergic asthma. J Allergy Clin Immunol 1991; 87: 794-802
17. Ohnishi T, Kita H, Weiler D, et al. IL-5 is the predominant eosinophil-active cytokine in the antigen-induced pulmonary late-phase reaction. Am Rev Respir Dis 1993; 147: 901-907.
18. Adachi T, Motojima S, Hirata A, Fukuda T, Makino S. Eosinophil viability-enhancing activity in sputum from patients with bronchial asthma. Am J Respir Crit Care Med 1995; 151: 618-623.
19. American Thoracic Society. Standards for the diagnosis and treatment of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1989; 136: 225-244.
20. Gartner I. Separation of human eosinophils in density gradients of polyvinylpyrrolidone-coated silica gel (Percoll). Immunology 1980; 40: 113-136.
21. Miltenyi S, Pfluger S. High gradient magnetic cell sorting. In: Radbruch A, ed. Flow Cytometry and Cell Sorting. Hong Kong, Springer, 1992; pp. 141-152.
22. Yokoyama WM. Flow cytometry analysis using the Becton Dickinson FACScan. In: Coligan JE, Kruisbeck AM, Margulies DH, et al. eds. Current Protocols in Immunology. New York, Green Publishing Associates and Wiley-Interscience, 1991; unit 5.4.
23. Jarjour NN, Busse WW. Cytokines in bronchoalveolar lavage fluid of patients with nocturnal asthma. Am J Respir Crit Care Med 1995; 152: 1474-1477.
24. Ohnishi T, Kita H, Mayeno AN, et al. Lidocaine in bronchoalveolar lavage fluid (BALF) is an inhibitor of eosinophil-active cytokines. Clin Exp Immunol 1996; 104: 325-331.
25. Girgis-Gabardo A, Kanai N, Denburg JA, Hargreave FE, Jordana M, Dolovich J. Immunocytochemical detection of granulocyte-macrophage colony-stimulating factor and eosinophil cationic protein in sputum cells. J Allergy Clin Immunol 1994; 93: 945-947.
26. Broide DH, Paine MM, Firestein GS. Eosinophils express interleukin 5 and granulocyte macrophage-colony stimulating factor mRNA at sites of allergic inflammation in asthmatics. J Clin Invest 1992; 90: 1414-1424.
27. Zang S, Mohammed Q, Burbidge A, Morland CM, Roche WR. Cell cultures from bronchial subepithelial myofibroblasts enhance eosinophil survival in vitro. Eur Respir J 1996; 9: 1839-1846.
28. Park CS, Lee SM, Uh ST, et al. Soluble interleukin-2 receptor and cellular profiles in bronchoalveolar lavage fluid from patients with bronchial asthma. J Allergy Clin Immunol 1993; 91: 623-633.
29. Nakamura Y, Ozaki T, Kamei T, et al. Increased granulocyte/macrophage colony-stimulating factor production by mononuclear cells from peripheral blood of patients with bronchial asthma. Am Rev Respir Dis 1993; 147: 87-91.
30. Till S, Li Baiqing, Durham S, et al. Secretion of the eosinophil-active cytokines interleukin-5, granulocyte/macrophage colony-stimulating factor and interleukin-3 by bronchoalveolar lavage CD4+ and CD8+ T-cell lines in atopic asthmatics, and atopic and non-atopic controls. Eur J Immunol 1995; 25: 2727-2731.
31. Yasruel Z, Humbert M, Kotsimbos C, et al. Membrane-bound and soluble αIL-5 receptor mRNA in the bronchial mucosa of atopic and nonatopic asthmatics. Am J Respir Crit Care Med 1997; 155: 1413-1418.
32. Kotsimbos ATC, Humbert M, Minshall E, et al. Upregulation of GM-CSF-receptor in nonatopic asthma but not in atopic asthma. J Allergy Clin Immunol 1997; 99: 666-672.
33. Park TW, G-I Lim, SH Moon, et al. Expression of IL-3, IL-5 and GM-CSF on the airway mucosa of asthmatics. J Korean Soc Allergol 1995; 15: 482.